G1 Therapeutics Stock Forecast - Accumulation Distribution
| GTHXDelisted Stock | USD 7.15 0.00 0.00% |
GTHX Stock Forecast is based on your current time horizon.
GTHX |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 316688.0 | 85680.3 |
| Check G1 Therapeutics Volatility | Backtest G1 Therapeutics | Trend Details |
G1 Therapeutics Trading Date Momentum
| On June 27 2024 G1 Therapeutics was traded for 2.25 at the closing time. The top price for the day was 2.56 and the lowest listed price was 2.23 . The trading volume for the day was 1.2 M. The trading history from June 27, 2024 did not cause price change. The overall trading delta against the current closing price is 7.56% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare G1 Therapeutics to competition
View G1 Therapeutics Related Equities
| Risk & Return | Correlation |
G1 Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how G1 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading G1 Therapeutics shares will generate the highest return on investment. By undertsting and applying G1 Therapeutics stock market strength indicators, traders can identify G1 Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0028 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 7.15 | |||
| Day Typical Price | 7.15 | |||
| Market Facilitation Index | 0.02 |
G1 Therapeutics Risk Indicators
The analysis of G1 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in G1 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gthx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.77 | |||
| Semi Deviation | 1.98 | |||
| Standard Deviation | 8.77 | |||
| Variance | 76.95 | |||
| Downside Variance | 12.66 | |||
| Semi Variance | 3.91 | |||
| Expected Short fall | (5.42) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in GTHX Stock
If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |